A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Pepponi, I, Khatri, B, Tanner, R, Villarreal-Ramos, B, Vordermeier, M, McShane, H
Format:	Journal article
Wydane:	Elsevier 2017

Podobne zapisy

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
od: Brennan, M, i wsp.
Wydane: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
od: Tanner, R, i wsp.
Wydane: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
od: Tanner, R, i wsp.
Wydane: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
od: Rachel Tanner, i wsp.
Wydane: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
od: Rachel Tanner, i wsp.
Wydane: (2021-09-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
od: Painter, H, i wsp.
Wydane: (2024)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
od: Tanner, R
Wydane: (2015)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
od: Tanner, R, i wsp.
Wydane: (2020)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
od: Painter, H, i wsp.
Wydane: (2024)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
od: Hannah Painter, i wsp.
Wydane: (2024-02-01)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
od: McShane, H, i wsp.
Wydane: (2016)

The humoral immune response to BCG vaccination
od: Tanner, R, i wsp.
Wydane: (2019)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
od: Rachel Tanner, i wsp.
Wydane: (2020-01-01)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
od: Mcshane, H, i wsp.
Wydane: (2017)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
od: Tanner, R, i wsp.
Wydane: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
od: Marsay, L, i wsp.
Wydane: (2013)

The Humoral Immune Response to BCG Vaccination
od: Rachel Tanner, i wsp.
Wydane: (2019-06-01)

Towards new TB vaccines
od: Brazier, B, i wsp.
Wydane: (2020)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
od: Tanner, R, i wsp.
Wydane: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
od: Marsay, L, i wsp.
Wydane: (2013)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
od: Tanner, R, i wsp.
Wydane: (2019)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
od: Biffar, L, i wsp.
Wydane: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
od: Dean, G, i wsp.
Wydane: (2014)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
od: Fletcher, H, i wsp.
Wydane: (2013)

TB vaccines in clinical development
od: Ginsberg, AM, i wsp.
Wydane: (2016)

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity
od: Emil Joseph Vergara, i wsp.
Wydane: (2024-07-01)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
od: Hyejon Lee, i wsp.
Wydane: (2019-04-01)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
od: Vordermeier, H, i wsp.
Wydane: (2009)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
od: Painter, H, i wsp.
Wydane: (2020)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
od: Villarreal-Ramos, B, i wsp.
Wydane: (2017)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
od: Hannah Painter, i wsp.
Wydane: (2020-02-01)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
od: O'Shea, M, i wsp.
Wydane: (2018)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
od: Dean, G, i wsp.
Wydane: (2014)

A review of clinical models for the evaluation of human TB vaccines.
od: O'Shea, M, i wsp.
Wydane: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
od: Vordermeier, H, i wsp.
Wydane: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
od: Tanner, R, i wsp.
Wydane: (2021)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
od: Vordermeier, H, i wsp.
Wydane: (2011)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
od: Matthew K. O’Shea, i wsp.
Wydane: (2018-09-01)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
od: Rachel Tanner, i wsp.
Wydane: (2021-01-01)

Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis
od: Bindu Dasan, i wsp.
Wydane: (2025-01-01)